Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Dacarbazine (compound)
Most Correlated Studies
- Gene profile of glioblastoma cells treated with y15 and temozolomide
- Hodgkin Reed-Sternberg cells response to ABVD chemotherapy treatment
- Glioblastoma stem cells resistant or sensitive to radiation or radiation and temozolomide
- U-87 glioma cell line with NFkB subunit p105 shRNA knockdown and temozolomide (TMZ) treatment
- Cerebral tumors response to treatment with Temodal (TMZ) in a glioblastoma mouse model
Most Relevant Literature
- A Case of Long-Term Survival with Tumor Resection and DOX plus DTIC Therapy for Desmoid Tumor after …
- CD47-mediated DTIC-loaded chitosan oligosaccharide-grafted nGO for synergistic chemo-photothermal th…
- Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III…
- Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent.
- Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
Most Relevant Clinical Trials
- Dacarbazine and Carmustine in Metastatic Melanoma
- Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
- Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma
- Sorafenib and Dacarbazine in Soft Tissue Sarcoma
- Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma
